Abstract
Purpose
This study evaluated the feasibility and utility of longitudinal cough frequency monitoring with the Hyfe Cough Tracker, a mobile application equipped with cough-counting artificial intelligence algorithms, in real-world patients with chronic cough.
Methods
Patients with chronic cough (> 8-week duration) were monitored continuously for cough frequency with the Hyfe app for at least one week. Cough was also evaluated using the Leicester Cough Questionnaire (LCQ) and daily cough severity scoring (0–10). The study analyzed adherence rate, the correlation between objective cough frequency and subjective scores, day-to-day variability, and patient experience.
Results
Of 65 subjects consecutively recruited, 43 completed the study. The median cough monitoring duration was 13.9Â days, with a median adherence of 91%. Study completion was associated with baseline cough severity, and the adherence rate was higher in younger subjects. Cross-sectional correlation analyses showed modest correlations between objective and subjective cough measures at the group level. However, in time series correlation analyses, correlations between objective and subjective measures widely varied across individuals. Cough frequency had greater day-to-day variability than daily cough severity scores in most subjects. A patient experience survey found that 70% of participants found the cough monitoring helpful, 86% considered it acceptable, and 84% felt it was easy to use.
Conclusion
Monitoring cough frequency longitudinally for at least one week may be feasible. The substantial day-to-day variability in objective cough frequency highlights the need for continuous monitoring. Grasping the implications of daily cough variability is crucial in both clinical practice and clinical trials.
This is a preview of subscription content, access via your institution.



References
Morice AH, Fontana GA, Belvisi MG, Birring SS, Chung KF, Dicpinigaitis PV, Kastelik JA, McGarvey LP, Smith JA, Tatar M, Widdicombe J, European Respiratory S (2007) ERS guidelines on the assessment of cough. Eur Respir J 29(6):1256–1276
Crooks MG, den Brinker AC, Thackray-Nocera S, van Dinther R, Wright CE, Morice AH (2021) Domiciliary cough monitoring for the prediction of COPD exacerbations. Lung 199(2):131–137
Faruqi S, Sykes DL, Crooks MG, Brindle K, Thompson J, Morice AH (2020) Objective assessment of cough: an early marker of response to biological therapies in asthma? Lung 198(5):767–770
Do W, Russell R, Wheeler C, Javed H, Dogan C, Cunningham G, Khanna V, De Vos M, Satia I, Bafadhel M (2022) Performance of cough monitoring by Albus Home, a contactless and automated system for nocturnal respiratory monitoring at home. ERJ Open Res 8(4):00265–02022
Porter P, Brisbane J, Abeyratne U, Bear N, Claxton S (2022) A smartphone-based algorithm comprising cough analysis and patient-reported symptoms identifies acute exacerbations of asthma: a prospective, double blind, diagnostic accuracy study. J Asthma 60:368–376
Huddart S, Asege L, Jaganath D, Golla M, Dang H, Lovelina L, Derendinger B, Andama A, Christopher D, Nhung N (2023) Continuous cough monitoring: a novel digital biomarker for TB diagnosis and treatment response monitoring. Int J Tuberc Lung Dis 27(3):221–222
Altshuler E, Tannir B, Jolicoeur G, Rudd M, Saleem C, Cherabuddi K, Dore DH, Nagarsheth P, Brew J, Small PM, Glenn Morris J, Grandjean Lapierre S (2023) Digital cough monitoring—a potential predictive acoustic biomarker of clinical outcomes in hospitalized COVID-19 patients. J Biomed Inform 138:104283
Gabaldón-Figueira JC, Keen E, Giménez G, Orrillo V, Blavia I, Doré DH, Armendáriz N, Chaccour J, Fernandez-Montero A, Bartolomé J (2022) Acoustic surveillance of cough for detecting respiratory disease using artificial intelligence. ERJ Open Res 8(2):00053–02022
Tinschert P, Rassouli F, Barata F, Steurer-Stey C, Fleisch E, Puhan MA, Kowatsch T, Brutsche MH (2020) Nocturnal cough and sleep quality to assess asthma control and predict attacks. J Asthma Allergy 13:669–678
Zhang M, Brindle K, Robinson M, Ingram D, Cavany T, Morice A (2022) Chronic cough in cystic fibrosis: the effect of modulator therapy on objective 24-h cough monitoring. ERJ Open Res 8(2):00031–02022
McGarvey L, Gibson PG (2019) What is chronic cough? terminology. J Allergy Clin Immunol Pract 7(6):1711–1714
Morice AH, Millqvist E, Bieksiene K et al (2020) ERS guidelines on the diagnosis and treatment of chronic cough in adults and children. Eur Respir J 55(1):1901136
McGarvey LP, Birring SS, Morice AH et al (2022) Efficacy and safety of gefapixant, a P2X(3) receptor antagonist, in refractory chronic cough and unexplained chronic cough (COUGH-1 and COUGH-2): results from two double-blind, randomised, parallel-group, placebo-controlled, phase 3 trials. Lancet 399(10328):909–923
Dicpinigaitis PV, Morice AH, Smith JA et al (2023) Efficacy and safety of eliapixant in refractory chronic cough: the randomized, placebo-controlled phase 2b PAGANINI study. Lung 201(3):255–266
McGarvey L, Smith JA, Morice A et al (2023) A Randomized, double-blind, placebo-controlled, parallel-group phase 2b trial of P2X3 receptor antagonist sivopixant for refractory or unexplained chronic cough. Lung 201(1):25–35
Birring SS, Fleming T, Matos S, Raj AA, Evans DH, Pavord ID (2008) The leicester cough monitor: preliminary validation of an automated cough detection system in chronic cough. Eur Respir J 31(5):1013–1018
Smith JA, Holt K, Dockry R, Sen S, Sheppard K, Turner P, Czyzyk P, McGuinness K (2021) Performance of a digital signal processing algorithm for the accurate quantification of cough frequency. Eur Respir J 58(2):2004271
Kang YR, Oh JY, Lee JH, Small PM, Chung KF, Song WJ (2022) Long-COVID severe refractory cough: discussion of a case with 6-week longitudinal cough characterization. Asia Pac Allergy 12(2):e19
Rudd M, Song W-J, Small PM (2022) The statistics of counting coughs: easy as 1, 2, 3? Lung 200(5):531–537
Rassouli F, Tinschert P, Barata F, Steurer-Stey C, Fleisch E, Puhan MA, Baty F, Kowatsch T, Brutsche MH (2020) Characteristics of asthma-related nocturnal cough: a potential new digital biomarker. J Asthma Allergy 13:649–657
Liaqat D, Liaqat S, Chen JL, Sedaghat T, Gabel M, Rudzicz F, de Lara E Coughwatch: Real-world cough detection using smartwatches. In: ICASSP 2021–2021 IEEE International Conference on Acoustics, Speech and Signal Processing (ICASSP), 2021. IEEE, pp 8333–8337
Jokić S, Cleres D, Rassouli F, Steurer-Stey C, Puhan MA, Brutsche M, Fleisch E, Barata F (2022) TripletCough: cougher identification and verification from contact-free smartphone-based audio recordings using metric learning. IEEE J Biomed Health Inform 26(6):2746–2757
Kruizinga MD, Zhuparris A, Dessing E, Krol FJ, Sprij AJ, Doll RJ, Stuurman FE, Exadaktylos V, Driessen GJ, Cohen AF (2022) Development and technical validation of a smartphone-based pediatric cough detection algorithm. Pediatr Pulmonol 57(3):761–767
Barata F, Cleres D, Tinschert P, Iris Shih CH, Rassouli F, Boesch M, Brutsche M, Fleisch E (2023) Nighttime continuous contactless smartphone-based cough monitoring for the ward: validation study. JMIR Form Res 7:e38439
Shim J-S, Kim M-H, Lee SM, Kim S-H, Kwon J-W, Song C, Ahn K-M, Kang S-Y, Park H-K, Park H-W (2023) An artificial intelligence algorithm-based smartphone application for daily cough monitoring. Allergy 78:1378–1380
Kuhn M, Nalbant E, Kohlbrenner D, Alge M, Kuett L, Arvaji A, Sievi NA, Russi EW, Clarenbach CF (2023) Validation of a small cough detector. ERJ Open Res 9(1):00279–02022
Gabaldón-Figueira JC, Keen E, Rudd M, Orrilo V, Blavia I, Chaccour J, Galvosas M, Small P, Lapierre SG, Chaccour C (2022) Longitudinal passive cough monitoring and its implications for detecting changes in clinical status. ERJ Open Res 8(2):00001–02022
Song DJ, Song WJ, Kwon JW et al (2018) KAAACI evidence-based clinical practice guidelines for chronic cough in adults and children in Korea. Allergy Asthma Immunol Res 10(6):591–613
Gabaldon-Figueira JC, Brew J, Dore DH, Umashankar N, Chaccour J, Orrillo V, Tsang LY, Blavia I, Fernandez-Montero A, Bartolome J, Grandjean Lapierre S, Chaccour C (2021) Digital acoustic surveillance for early detection of respiratory disease outbreaks in Spain: a protocol for an observational study. BMJ Open 11(7):e051278
Vertigan AE, Kapela SL, Birring SS, Gibson PG (2021) Feasibility and clinical utility of ambulatory cough monitoring in an outpatient clinical setting: a real-world retrospective evaluation. ERJ Open Res 7(4):00319–02021
Kelsall A, Decalmer S, Webster D, Brown N, McGuinness K, Woodcock A, Smith J (2008) How to quantify coughing: correlations with quality of life in chronic cough. Eur Respir J 32(1):175–179
Faruqi S, Thompson R, Wright C, Sheedy W, Morice AH (2011) Quantifying chronic cough: objective versus subjective measurements. Respirology 16(2):314–320
Birring SS, Matos S, Patel RB, Prudon B, Evans DH, Pavord ID (2006) Cough frequency, cough sensitivity and health status in patients with chronic cough. Respir Med 100(6):1105–1109
Kum E, Guyatt GH, Devji T, Wang Y, Bakaa L, Lan L, Liu E, Mastrolonardo A, Couban R, O’Byrne PM, Satia I (2021) Cough symptom severity in patients with refractory or unexplained chronic cough: a systematic survey and conceptual framework. Eur Respir Rev 30(161):210104
Kum E, Guyatt GH, Munoz C et al (2022) Assessing cough symptom severity in refractory or unexplained chronic cough: findings from patient focus groups and an international expert panel. ERJ Open Res 8(1):00667–02021
Funding
None.
Author information
Authors and Affiliations
Contributions
WJS is the full guarantor of this manuscript. SEL, PMS, KFC, and WJS contributed to the study conception and design and data interpretation. THK, JYO, JHL, and LJ have made contributions to the data acquisition. SEL and MR performed formal analysis. SEL and WJS drafted the first version of the manuscript. PMS, KFC, and WJS supervised and revised the manuscript. All authors approved this version of the manuscript for submission.
Corresponding author
Ethics declarations
Conflict of interests
SEL, THK, JYO, JHL, and WJS declare no related financial interests. MR, LJ, and PMS are employees of Hyfe Inc. KFC has received honoraria for participating in Advisory Board meetings of Roche, Merck, Novartis, GSK, Nocion, Shionogi, and Rickett-Beckinson and has also been renumerated for speaking engagements for Novartis and AZ. No authors received financial compensation for participation in this work.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Lee, SE., Rudd, M., Kim, TH. et al. Feasibility and Utility of a Smartphone Application-Based Longitudinal Cough Monitoring in Chronic Cough Patients in a Real-World Setting. Lung 201, 555–564 (2023). https://doi.org/10.1007/s00408-023-00647-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00408-023-00647-1